Filing Details
Advanced Biomed Inc. (NASDAQ:ADVB) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event.
8k filedNASDAQ:ADVB
Advanced Biomed Inc. (ADVB) Reports Material Event to SEC
Filing Details Advanced Biomed Inc. (NASDAQ:ADVB) filed a Form 8-K with the Securities and Exchange Commission on July 17, 2026, disclosing a material event. Market Context…
Market Context
Advanced Biomed Inc.'s stock currently trades at $5.03 with a market capitalization of $4.4M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Advanced Biomed Inc.'s stock.
All SEC filings for Advanced Biomed Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View ADVB Stock Page
Frequently Asked Questions
Where can I read ADVB's SEC filings?
Browse all filings on our ADVB SEC filings page.
What types of SEC filings does Advanced Biomed Inc. file?
Public companies like Advanced Biomed Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.